Patients with traumatic brain injury were more likely to collect work disability benefits, with odds increasing with the severity of the injury, than patients who did not have these injuries, according to a study published in Neurology.
These findings indicate a need to address impairment related to these injuries as well as socioeconomics and comorbidities during long-term, individualized rehabilitation, the researchers wrote.
“Most studies of traumatic brain injury (TBI) measure return to work as a simple yes-or-no outcome at one time point,” study authors Andrea Klang, MD, a PhD student,

PHILADELPHIA — Patients at risk for anaphylaxis as well as caregivers of children at risk preferred needle-free epinephrine, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
These patients and caregivers may be afraid of needles, limiting how promptly they use autoinjectors, De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP, chief research officer at Allergy & Asthma Network, and colleagues wrote on their poster.
The size of autoinjectors also discourages patients and caregivers from carrying them, the researchers wrote. But despite the

PHILADELPHIA — Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Notably, this was true in three different BMI classes, according to the study.
“This research suggests that GLP-1 medications may have meaningful respiratory benefits beyond weight loss or glucose control,” Ruchi Patel, MD, resident physician at Rutgers New Jersey Medical School, told Healio. “It highlights a potential new therapeutic avenue for patients